TrialNet is an international network of leading academic institutions, physicians, scientists and healthcare teams dedicated to the prevention of type 1 diabetes. TrialNet offer risk screening for relatives of people with type 1 diabetes and innovative clinical studies to prevent the clinical onset of diabetes and to preserve insulin production. TrialNet, supported by NIH, is found at https://www.trialnet.org/. The international sites are supported by the Juvenile Diabetes Research Foundation (JDRF). The Lund University site is TrialNet Center Sweden (https://www.med.lu.se/trialnet/vill_du_vara_med).
|Gällande start-/slutdatum||2010/08/31 → 2020/08/15|